These categories should not be merged into a single conclusion because each has distinct experimental controls, sources of bias, and interpretive limits
People using tirzepatide for weight management alone may experience a slower metabolic shift by comparison
Digestive symptoms Some people experience temporary digestive changes as their system readjusts to normal gastric emptying speeds after stopping semaglutide
Major cardiovascular event risk reduction that matters Wegovy is the only GLP-1 RA indicated for weight loss proven to help prevent life-threatening CV events for adults with established CVD and either overweight or obesity, along with diet and exercise 1,4,5 BMI, body mass index
2 Conclusion The use of sedation and anaesthesia in dentistry boasts an exemplary safety record, contributing to its widespread acceptance and utilisation in the ambulatory and hospital settings
These effects are typically mild to moderate and decrease over time